Eight-years Egyptian experience of Boston type I keratoprosthesis following failed penetrating keratoplasty or ocular surface disease

被引:2
|
作者
Othman, Ihab S. [1 ,2 ]
Gharieb, Hesham M. [3 ,4 ]
Ibrahim, Hani M. G. [2 ,4 ]
机构
[1] Cairo Univ, Fac Med, Dept Ophthalmol, Giza, Egypt
[2] Eye World Hosp, Giza, Egypt
[3] Eye World Hosp, Dept CMD & Head R&D, Giza, Egypt
[4] Ain Shams Univ, Fac Med, Cairo, Egypt
关键词
Boston keratoprosthesis; extruded prosthesis; ocular surface disease; penetrating keratoplasty; OUTCOMES;
D O I
10.4103/sjopt.sjopt_36_20
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To evaluate the outcome and complications after implantation of the Boston type I keratoprosthesis (Kpro) in two groups of eyes. METHODS: We retrospectively reviewed records of 28 eyes with failed Penetrating keratoplasty (PKP) (Group A) and 31 eyes with severe ocular surface diseases who implanted Kpro. Follow-up was performed for a mean 37 months. Primary outcomes were Kpro retention and visual improvement, secondary outcomes included the occurrence of complications as endophthalmitis, retro-prosthesis membrane (RPM), intraocular pressure (IOP) abnormalities, posterior capsule opacification (PCO), graft thinning and extrusion. RESULTS: Visual improvement was achieved in 20 eyes in Group A, and in 19 eyes in Group B. In group A, the prosthesis was retained in 25 eyes, while prosthesis retention in Group B was in 26 eyes. Group A had higher rates of PCO, high IOP, soft IOP, and graft thinning. Group B had higher risk of RPM, and endophthalmitis. Two eyes in Group A, and Five eyes in Group B required redo procedure. CONCLUSION: The Boston Kpro type I is an effective procedure in eyes with high risk of keratoplasty failure and in severe ocular surface diseases, it has a high retention rate, higher in cases following failed PKP.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 13 条
  • [1] Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft
    Jonathan El-Khoury
    Diana Khair
    Roy Daoud
    Paul Thompson
    Louis Racine
    Mona Harissi-Dagher
    Eye, 2023, 37 : 486 - 491
  • [2] Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft
    El-Khoury, Jonathan
    Khair, Diana
    Daoud, Roy
    Thompson, Paul
    Racine, Louis
    Harissi-Dagher, Mona
    EYE, 2023, 37 (03) : 486 - 491
  • [3] Comparison of the Clinical Efficacy of Boston Keratoprosthesis Type I and Repetitive Penetrating Keratoplasty for Refractory Keratopathy
    Chen, Yingxin
    Wang, Cuiyu
    Liu, Qiming
    Wang, Ziyue
    Gao, Minghong
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (02) : E194 - E199
  • [4] The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis
    Bonneau, Steven
    Tong, C. Maya
    Yang, Yelin
    Harissi-Dagher, Mona
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (09) : 2781 - 2790
  • [5] The treatment of end-stage corneal disease: penetrating keratoplasty compared with Boston type 1 keratoprosthesis
    Steven Bonneau
    C. Maya Tong
    Yelin Yang
    Mona Harissi-Dagher
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2781 - 2790
  • [6] Ocular Surface, Fornix, and Eyelid Rehabilitation in Boston Type I Keratoprosthesis Patients With Mucous Membrane Disease
    Rootman, Dan B.
    Kim, Michelle J.
    Aldave, Anthony J.
    Douglas, Raymond
    Hwang, Catherine
    Goldberg, Robert
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2015, 31 (01): : 43 - 49
  • [7] Boston Type I Keratoprosthesis Implantation Following Autologous Submandibular Gland Transplantation for End Stage Ocular Surface Disorders
    Gu, Jianjun
    Zhai, Jiajie
    Liao, Guiqing
    Chen, Jiaqi
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (03) : 452 - 455
  • [8] Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
    Saini, Chhavi
    Chen, Teresa C.
    Young, Lucy H.
    Vavvas, Demetrios G.
    Vangel, Mark
    Papaliodis, George N.
    Mukai, Shizuo
    V. Turalba, Angela
    Rhee, Douglas J.
    Wu, David M.
    Eliott, Dean
    Miller, John B.
    Song, Brian J.
    Shen, Lucy Q.
    Pasquale, Louis R.
    Chodosh, James
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 243 : 42 - 54
  • [9] Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study
    Yuying Zhang
    Zhancong Ou
    Jin Zhou
    Jiajie Zhai
    Jianjun Gu
    Jiaqi Chen
    Advances in Therapy, 2020, 37 : 3206 - 3222
  • [10] Treatment of Oculoplastic and Ocular Surface Disease in Eyes Implanted with a Type I Boston Keratoprosthesis in Southern China: A Retrospective Study
    Zhang, Yuying
    Ou, Zhancong
    Zhou, Jin
    Zhai, Jiajie
    Gu, Jianjun
    Chen, Jiaqi
    ADVANCES IN THERAPY, 2020, 37 (07) : 3206 - 3222